2021
DOI: 10.3389/fcell.2021.664535
|View full text |Cite
|
Sign up to set email alerts
|

A Selective Review of the Excitatory-Inhibitory Imbalance in Schizophrenia: Underlying Biology, Genetics, Microcircuits, and Symptoms

Abstract: Schizophrenia is a chronic disorder characterized by specific positive and negative primary symptoms, social behavior disturbances and cognitive deficits (e.g., impairment in working memory and cognitive flexibility). Mounting evidence suggests that altered excitability and inhibition at the molecular, cellular, circuit and network level might be the basis for the pathophysiology of neurodevelopmental and neuropsychiatric disorders such as schizophrenia. In the past decades, human and animal studies have ident… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
29
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 37 publications
(32 citation statements)
references
References 177 publications
3
29
0
Order By: Relevance
“…In this study, we demonstrate that MIA can induce methylation changes to known DEGs in schizophrenia brains. The majority of these enriched genes were specific to cortical excitatory and inhibitory neurons, which is in line with the imbalance of excitatory-inhibitory transmission that has long been considered a key feature of schizophrenia (Liu et al, 2021). However, we were unable to detect enrichment of GWAS-associated schizophrenia genes among the DMGs following MIA.…”
Section: Discussionmentioning
confidence: 58%
“…In this study, we demonstrate that MIA can induce methylation changes to known DEGs in schizophrenia brains. The majority of these enriched genes were specific to cortical excitatory and inhibitory neurons, which is in line with the imbalance of excitatory-inhibitory transmission that has long been considered a key feature of schizophrenia (Liu et al, 2021). However, we were unable to detect enrichment of GWAS-associated schizophrenia genes among the DMGs following MIA.…”
Section: Discussionmentioning
confidence: 58%
“…NX210c thus presents a therapeutic opportunity to enhance excitatory neurotransmission in different disorders and states where glutamatergic synaptic transmission is impaired, such as schizophrenia [ 14 , 15 ], AD [ 17 , 18 , 20 ], Parkinson’s disease [ 19 , 20 ], unresponsive wakefulness syndrome [ 23 ], and even normal aging [ 24 , 25 ]. In addition, a reduction in glutamatergic system activity is often associated with a reduction in GABAergic system activity to maintain the balance between excitatory and inhibitory transmissions [ 23 , 37 , 38 , 39 ]; the activity of both systems could therefore be enhanced by an exogenous supply of NX210c. One major challenge in treating excitatory synaptic dysfunction is to reach a fast rebalancing of excitation and inhibition within the CNS without promoting excitotoxic neuronal death.…”
Section: Discussionmentioning
confidence: 99%
“…Research now suggests psychological function is driven by an underlying relationship of the two opposing electro-physiological state actions, excitation and inhibition (E/I). Importantly, findings suggest certain behavioral phenotypes or traits may be correlated with E/I balance or imbalance (Liu et al, 2021).…”
Section: State Vs Traitmentioning
confidence: 98%